303,85 €
1,43 % vorgestern
L&S, 3. Oktober, 22:54 Uhr
ISIN
BMG3223R1088
Symbol
EG
Berichte

Everest Reinsurance Group Aktie News

Neutral
Business Wire
5 Tage alt
SAN ANTONIO, Texas--(BUSINESS WIRE)--Carenet Health has been recognized as a Major Contender in Everest Group's 2025 PEAK Matrix® Assessment for Clinical and Care Management (CCM) Operations Platforms for Payers. This prestigious recognition reinforces Carenet's position as a leading healthcare technology partner, empowering payers to achieve measurable improvements in engagement, efficiency, a...
Neutral
Business Wire
10 Tage alt
HAMILTON, Bermuda--(BUSINESS WIRE)--Everest Group, Ltd. (NYSE: EG), a global underwriting leader providing best-in-class property, casualty, and specialty reinsurance and insurance solutions, today reported that Ricardo Anzaldua, EVP and General Counsel has announced his intention to retire in the coming months. The Company has commenced a search to identify a successor. In the interim, Mr. Anz...
Neutral
Business Wire
12 Tage alt
HAMILTON, Bermuda--(BUSINESS WIRE)--Everest Group, Ltd. (“Everest”) (NYSE: EG) will hold its third quarter 2025 earnings conference call on Thursday, October 30, 2025, beginning at 8:00 am Eastern Time. Dial in details can be obtained by completing the registration form available at: https://dpregister.com/sreg/10202575/ffd1c06314 The call can be accessed via a live, listen only webcast at www....
Neutral
PRNewsWire
18 Tage alt
Reflects consistent revenue growth and industry-defining performance among global peers SANTA CLARA, Calif. and PUNE, India , Sept.
Negativ
Seeking Alpha
etwa ein Monat alt
Everest shares have underperformed given concerns about reserves and pricing trends. While pricing caps margin upside, we are not seeing activity that will pressure margins. Everest is meaningfully shifting its exposures, which should support improved underwriting results with Q3 likely to be strong.
Neutral
GlobeNewsWire
etwa ein Monat alt
Medidata eCOA was the highest Leader recognized in the evaluation, supporting over 1M+ patients and reducing study build timeline by up to 50% compared to the industry standard Medidata eCOA was the highest Leader recognized in the evaluation, supporting over 1M+ patients and reducing study build timeline by up to 50% compared to the industry standard
Neutral
GlobeNewsWire
etwa ein Monat alt
YPrime, a proven leader in clinical trial technology, today announced it has been recognized as a Leader in the Everest Group's Life Sciences Electronic
Neutral
Business Wire
etwa ein Monat alt
NEW YORK--(BUSINESS WIRE)-- #25years--eClerx Recognized as a Leader & Star Performer in Everest Group's Capital Markets Operations Services PEAK Matrix® 2025.

Kostenlos registrieren

aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.

Die Apple Aktie im Überblick mit Charts, aktuellen Kennzahlen, Nachrichten und Aktienanalysen.
Die besten Dividenden-Aktien in der Dividenden-Topscorer-Liste.
Aktienanalysen der besten Aktien weltweit.
Jetzt Vermögen aufbauen